Bernstein Reaffirms Outperform Rating on UnitedHealth Amid Strong Momentum
UnitedHealth Group's (UNH) stock price has been boosted by analysts at Bernstein SocGen Group, who have reiterated an Outperform rating and a $512.00 price target on the company.
The firm's analysis suggests that UNH is undervalued, with a Fair Value of $503.43 based on its past performance and current market position.
UnitedHealth has delivered strong momentum in recent months, with a 36% return over the past six months, driven by growth in Medicare Advantage and value-based care.
The company's Optum Insight unit is seen as a key driver of long-term growth for UNH, representing a potential growth engine beyond its current recovery in Medicare Advantage and value-based care.
Optum Insight provides technology, analytics, revenue cycle management, payment integrity, and other services to healthcare providers and payers, and Bernstein views it as the largest potential upside to the application of AI to healthcare businesses.